The Food and Drug Administration advisory panel is holding a second day of meetings on whether to loosen restrictions on certain unapproved peptide drugs. The panel voted Thursday to broaden access to four peptides. KFF Health News' Amy Maxmen has more.
The Food and Drug Administration advisory panel is holding a second day of meetings on whether to loosen restrictions on certain unapproved peptide drugs. The panel voted Thursday to broaden access to four peptides. KFF Health News' Amy Maxmen has more.
<iframe src="https://statesidedaily.com/embed/cluster/bcd3f57be5241c03b36346543b6c86a06bbd500c" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA panel considers loosening regulations on certain unapproved peptides"></iframe>
